Gitterman Wealth Management LLC Cuts Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Gitterman Wealth Management LLC cut its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 10.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 628 shares of the biotechnology company’s stock after selling 72 shares during the quarter. Gitterman Wealth Management LLC’s holdings in Axon Enterprise were worth $373,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. Asset Dedication LLC lifted its position in Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after buying an additional 18 shares during the last quarter. Bleakley Financial Group LLC lifted its position in Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after buying an additional 20 shares during the last quarter. Venturi Wealth Management LLC lifted its position in Axon Enterprise by 2.7% in the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after buying an additional 21 shares during the last quarter. Insigneo Advisory Services LLC lifted its position in Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after buying an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC lifted its position in Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after buying an additional 24 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Transactions at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jeffrey C. Kunins sold 1,370 shares of the company’s stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $639.14, for a total value of $875,621.80. Following the completion of the sale, the insider now owns 125,950 shares in the company, valued at approximately $80,499,683. This represents a 1.08 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,146 shares of company stock worth $3,262,847. Insiders own 6.10% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. TD Cowen began coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Needham & Company LLC reiterated a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 26th. Finally, Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $604.67.

Axon Enterprise Stock Performance

AXON stock opened at $556.26 on Friday. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a market capitalization of $42.62 billion, a P/E ratio of 143.74, a PEG ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business has a 50-day moving average price of $593.42 and a 200 day moving average price of $535.46.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.